SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-21-006458
Filing Date
2021-04-02
Accepted
2021-04-02 16:12:50
Documents
9
Period of Report
2021-05-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A sgmo_proxyx2021xdefxvs.htm DEF 14A 1069125
2 board_representationximage.jpg GRAPHIC 76847
3 macraesignaturea021.jpg GRAPHIC 28251
4 sangamo-2021cdagraphiccash.jpg GRAPHIC 241279
5 sangamo-2021cdagraphicceo2.jpg GRAPHIC 70039
6 sangamo-2021cdagraphicfact.jpg GRAPHIC 116239
7 sangamo-2021cdagraphicprim.jpg GRAPHIC 128981
8 sgmoproxycardp11.jpg GRAPHIC 206924
9 sgmoproxycardp21.jpg GRAPHIC 158636
  Complete submission text file 0001628280-21-006458.txt   2485735
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30171 | Film No.: 21802095
SIC: 2836 Biological Products, (No Diagnostic Substances)